Bulletin from the Extraordinary General Meeting of Hansa Medical AB (publ)
Lund, Sweden, 11 December 2018 - Hansa Medical AB (PR Newswire) (Nasdaq Stockholm: HMED) (“Hansa Medical” or the “Company”), today held an extraordinary general meeting. The extraordinary general meeting resolved to change Hansa Medical’s company name to Hansa Biopharma AB, in accordance with the board of directors’ proposal.“The new name Hansa Biopharma emphasizes our focus on the development and commercialization of biological drugs, biopharmaceuticals. This refinement of our profile is particularly important for the continued internationalization of our business and our investor base.”
